1. Home
  2. SLDB vs BLMN Comparison

SLDB vs BLMN Comparison

Compare SLDB & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$5.92

Market Cap

781.7M

Sector

Health Care

ML Signal

HOLD

Logo Bloomin' Brands Inc.

BLMN

Bloomin' Brands Inc.

HOLD

Current Price

$9.14

Market Cap

851.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDB
BLMN
Founded
2013
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
781.7M
851.9M
IPO Year
2017
2012

Fundamental Metrics

Financial Performance
Metric
SLDB
BLMN
Price
$5.92
$9.14
Analyst Decision
Strong Buy
Hold
Analyst Count
14
11
Target Price
★ $18.71
$11.86
AVG Volume (30 Days)
1.3M
★ 2.4M
Earning Date
11-02-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
34.97
★ 106.71
EPS
N/A
★ 1.01
Revenue
$8,094,000.00
★ $4,213,346,000.00
Revenue This Year
N/A
$0.65
Revenue Next Year
N/A
$1.66
P/E Ratio
★ N/A
$10.15
Revenue Growth
N/A
★ N/A
52 Week Low
$3.79
$5.19
52 Week High
$11.45
$12.63

Technical Indicators

Market Signals
Indicator
SLDB
BLMN
Relative Strength Index (RSI) 35.08 48.91
Support Level $5.38 $7.51
Resistance Level $7.26 $9.28
Average True Range (ATR) 0.42 0.50
MACD 0.06 0.13
Stochastic Oscillator 30.72 45.71

Price Performance

Historical Comparison
SLDB
BLMN

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc is a casual dining restaurant company, with a portfolio of, differentiated restaurant concepts. Its restaurant portfolio includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill and Fleming's Prime Steakhouse & Wine Bar. Its restaurant concepts range in price point and degree of formality from casual (Outback Steakhouse and Carrabba's Italian Grill) to polished casual (Bonefish Grill) and fine dining (Fleming's Prime Steakhouse & Wine Bar). The U.S. segment includes all restaurants operating in the U.S. while franchised restaurants operating outside the U.S. are included in the international franchise segment.

Share on Social Networks: